Steven E. Nissen, MD, chief academic officer of the Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute at the Cleveland Clinic, was the lead author on the Apollo Trial, a late-breaking ACC.22 study evaluating the effectiveness of an mRNA drug to suppress lipoprotein(a).

The new international consensus document gives detailed recommendations on when to offer genetic testing for patients and their family members. 

ACR and others have submitted a formal national coverage determination request, asking the agency to address payment gaps for virtual colonoscopies. 

The mandatory bundled payment initiative was slated to kick off Jan. 1, 2023, following numerous delays, but will now launch on a to-be-determined date.

An updated look at patients treated with Medtronic's renal denervation system was presented at ACC.22 and simultaneously published in The Lancet. 

The two companies said the agreement reflects their commitment to combining and desire to fight the Department of Justice's "meritless legal challenge to this merger." 

Read our in-person coverage of the final day of ACC.22.

Day 2 of ACC.22 was jam-packed with late-breaking clinical trials. Read our quick rundown of what researchers shared with the public for the very first time.